mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.6 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.6 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |